Growth through acquisitions HRS expanded its capabilities by acquiring Rimidi, signaling a strategy to broaden chronic disease management and remote monitoring offerings. This presents an opportunity to position complementary solutions that further Enhance cardiometabolic care and longitudinal management for health systems already invested in HRS.

Longitudinal care expansion With the launch of PatientFirst Pathways and its move into comprehensive longitudinal care at home, there is a clear pathway to upsell end-to-end remote care services to existing clients seeking to extend care across the patient journey.

Enterprise integration strength HRS’ out-of-the-box HL7 integration with major EHR brands and strong interoperability position makes it a attractive partner for health systems looking to modernize RPM programs without heavy IT burden. Target clients with ambitious interoperability needs and legacy systems.

Awarded value leadership Repeated recognition from Frost & Sullivan and other industry bodies for technology-enabled longitudinal care underscores a compelling value narrative for prospects focused on patient outcomes and cost containment. Use awards in outreach to differentiate proposals.

Scale with large networks Past wins with Queen’s Health Systems and emphasis on scalable deployment across diverse populations indicate readiness to engage multi-site health systems and regional health networks seeking scalable RPM and CCM programs that deliver measurable results.